Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CODX | Co-Diagnostics | $2.64 | -$3.34 | -55.78% | 1.2M | $13M | $2.36$46.50 |
| EMAT | Evolution Metals & Technologies | $9.44 | -$7.01 | -42.61% | 232.1K | $47M | $7.05$24.37 |
| ATRA | Atara Biotherapeutics | $4.37 | -$1.52 | -25.77% | 2.4M | $42M | $4.25$19.15 |
| RGC | Regencell Bioscience | $33.00 | -$11.11 | -25.19% | 778.3K | $22B | $0.09$83.60 |
| ELAB | Pmgc | $4.05 | -$1.22 | -23.10% | 453.6K | $2.7M | $3.54$398.86 |
| PASG | Passage Bio | $13.90 | -$4.01 | -22.39% | 92.4K | $56M | $5.12$20.00 |
| CVRX | CVRx | $6.10 | -$1.21 | -16.55% | 18K | $192M | $4.30$18.55 |
| FIGG | Themes ETF Trust - Leverage Shares 2x Long Fig Daily ETF | $3.68 | -$0.64 | -14.73% | 1.2M | - | $3.53$16.34 |
| TVTX | Travere Therapeutics | $29.12 | -$4.98 | -14.60% | 760.5K | $3.1B | $12.91$42.13 |
| ZEPP | Zepp Health | $22.80 | -$3.88 | -14.54% | 8.1K | $188M | $2.13$61.85 |
Related Articles
Featured Article
A Nearly 1,100% Gain: Here's the 1 Key Reason Why This Forgotten Tech Stock Crushed the S&P 500
Scott Levine|Dec 5, 2025
After years of struggling with one key metric, this tech company has found its way back onto investors' buy lists.
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
This Fitness Tech Stock Has Crushed Apple's 2025 Gains -- 1 Reason Why
Lyle Daly|Oct 19, 2025
The Amazfit brand has helped Zepp Health bounce back in a big way after years of negative returns.
Advertisement
These 5 Companies Were Huge Winners This Earnings Season. Can the Good Times Keep Rolling?
Jon Quast|Nov 10, 2023
One of these five stocks is trading at a low price and has a profit catalyst that's greater than anything on the horizon for the other four.
Could an FDA Approval Send This Stock Flying?
David Jagielski, CPA|Mar 1, 2023
Is now the time to load up on this struggling stock?
This Expert Says Companies Need to Constantly Align Their Strategy and Culture
Motley Fool Staff|Jun 24, 2022
It can lead to successful outcomes in a variety of ways.
If This 1 Thing Happens in 2022, I'll Buy This Under-the-Radar IPO Stock in a Heartbeat
Jon Quast|Jan 20, 2022
The company zigged where its competitors zagged, jump-starting an important long-term growth engine.
IPO Stock Udemy's Profit Margins Are Better Than They Look
Jon Quast|Nov 10, 2021
The company has the financial profile investors have come to love with marketplace businesses.
Does IPO Stock Udemy Have a Competitive Advantage?
Jon Quast and Travis Hoium|Nov 9, 2021
The key to a two-sided marketplace is to open both funnels as wide as possible and Udemy is doing that.
Co-Diagnostics: Buy the Dip?
Cory Renauer|Mar 29, 2021
Analysts following this coronavirus stock have darkened their post-pandemic outlook.
